These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24094290)

  • 1. Serum creatinine is associated with coronary disease risk even in the absence of metabolic disorders.
    Onat A; Yüksel H; Can G; Köroğlu B; Kaya A; Altay S
    Scand J Clin Lab Invest; 2013 Oct; 73(7):569-75. PubMed ID: 24094290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum total and high-density lipoprotein phospholipids: independent predictive value for cardiometabolic risk.
    Onat A; Altuğ Çakmak H; Can G; Yüksel M; Köroğlu B; Yüksel H
    Clin Nutr; 2014 Oct; 33(5):815-22. PubMed ID: 24246837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones.
    Onat A; Can G; Hergenç G; Küçükdurmaz Z; Uğur M; Yüksel H
    Cardiology; 2010; 115(4):297-306. PubMed ID: 20395681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.
    Onat A; Can G; Hergenç G; Uğur M; Yüksel H
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary disease risk curve of serum creatinine is linear in Turkish men, U-shaped in women.
    Onat A; Can G; Ademoğlu E; Çelik E; Karagöz A; Örnek E
    J Investig Med; 2013 Jan; 61(1):27-33. PubMed ID: 23160183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical biomarkers of high-density lipoprotein dysfunction among middle-aged Turks.
    Onat A; Can G; Murat S; Ciçek G; Örnek E; Yüksel H
    Anadolu Kardiyol Derg; 2012 Dec; 12(8):628-36. PubMed ID: 22968297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
    Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
    Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
    Gianfagna F; Veronesi G; Guasti L; Chambless LE; Brambilla P; Corrao G; Mancia G; Cesana G; Ferrario MM
    Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels.
    Onat A; Kömürcü-Bayrak E; Can G; Küçükdurmaz Z; Hergenç G; Erginel-Unaltuna N
    Nutrition; 2010 Oct; 26(10):975-80. PubMed ID: 20116212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
    Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
    Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects.
    Dullaart RP; de Boer JF; Annema W; Tietge UJ
    Obesity (Silver Spring); 2013 Feb; 21(2):361-6. PubMed ID: 23404653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.